Literature DB >> 19332141

In vivo evidence for the selective subcortical degeneration in Huntington's disease.

Gwenaëlle Douaud1, Timothy E Behrens, Cyril Poupon, Yann Cointepas, Saâd Jbabdi, Véronique Gaura, Narly Golestani, Pierre Krystkowiak, Christophe Verny, Philippe Damier, Anne-Catherine Bachoud-Lévi, Philippe Hantraye, Philippe Remy.   

Abstract

Although Huntington's disease is largely considered to be a subcortical disease, there is no clear consensus on whether all deep grey matter loss is a direct downstream consequence of the massive degeneration of the medium-size spiny neurons in the striatum. Our aim was to characterise in vivo such preferential degeneration by analysing various distinct diffusion imaging measures including mean diffusivity, anisotropy, fibre orientation (using the information of the principal diffusion direction) and white matter tractography. All results converged to demonstrate the selective degeneration of connections in subcortical grey and white matter, degeneration which was likely to originate with the death of the striatal medium-size spiny neurons. Indeed, we found a significant increase of MD and FA in all the subcortical grey matter structures involved in the cortico-striato-thalamo-cortical loops. The atypical striatal and pallidal increase of FA was concurrent to a decrease of the dispersion of the fibre orientation, unambiguously characterising a preferential loss of connections along specific radiating directions from these structures while some others are comparatively spared. Analysis of striatal and pallidal white matter tracts revealed that striato-pallidal projections were the most affected. The ability of DTI to uncover the impact of such neurodegenerative disease on some specific neuronal/axonal populations is a further step towards the future definition of a surrogate marker of this disease. Beyond Huntington's disease, we prove here that diffusion imaging technique, associated to adequate methodological analyses, can provide insight into any neurodegenerative disorder for which some neuronal populations or connections are selectively targeted over others.

Entities:  

Mesh:

Year:  2009        PMID: 19332141     DOI: 10.1016/j.neuroimage.2009.03.044

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  79 in total

1.  Basal ganglia atrophy in prodromal Huntington's disease is detectable over one year using automated segmentation.

Authors:  D S Adnan Majid; Adam R Aron; Wesley Thompson; Sarah Sheldon; Samar Hamza; Diederick Stoffers; Dominic Holland; Jody Goldstein; Jody Corey-Bloom; Anders M Dale
Journal:  Mov Disord       Date:  2011-09-19       Impact factor: 10.338

2.  Cortical metabolites as biomarkers in the R6/2 model of Huntington's disease.

Authors:  Lori Zacharoff; Ivan Tkac; Qingfeng Song; Chuanning Tang; Patrick J Bolan; Silvia Mangia; Pierre-Gilles Henry; Tongbin Li; Janet M Dubinsky
Journal:  J Cereb Blood Flow Metab       Date:  2011-11-02       Impact factor: 6.200

Review 3.  Huntington's disease: progress toward effective disease-modifying treatments and a cure.

Authors:  Carl D Johnson; Beverly L Davidson
Journal:  Hum Mol Genet       Date:  2010-04-26       Impact factor: 6.150

4.  Stability effects on results of diffusion tensor imaging analysis by reduction of the number of gradient directions due to motion artifacts: an application to presymptomatic Huntington's disease.

Authors:  Hans-Peter Müller; Sigurd D Süssmuth; G Bernhard Landwehrmeyer; Albert Ludolph; Sarah J Tabrizi; Stefan Kloppel; Jan Kassubek
Journal:  PLoS Curr       Date:  2011-12-12

5.  Quantitative Susceptibility Mapping Suggests Altered Brain Iron in Premanifest Huntington Disease.

Authors:  J M G van Bergen; J Hua; P G Unschuld; I A L Lim; C K Jones; R L Margolis; C A Ross; P C M van Zijl; X Li
Journal:  AJNR Am J Neuroradiol       Date:  2015-12-17       Impact factor: 3.825

6.  The Impact of Alcohol Use on Frontal White Matter in HIV.

Authors:  Joseph M Gullett; Damon G Lamb; Eric Porges; Adam J Woods; Jake Rieke; Paul Thompson; Neda Jahanshad; Talia M Nir; Karen Tashima; Ronald A Cohen
Journal:  Alcohol Clin Exp Res       Date:  2018-07-16       Impact factor: 3.455

7.  Stability of white matter changes related to Huntington's disease in the presence of imaging noise: a DTI study.

Authors:  Hans-Peter Müller; Volkmar Glauche; Marianne J U Novak; Thao Nguyen-Thanh; Alexander Unrath; Nayana Lahiri; Joy Read; Miranda Julia Say; Sarah J Tabrizi; Jan Kassubek; Stefan Kloppel
Journal:  PLoS Curr       Date:  2011-06-07

8.  Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington's disease.

Authors:  Eve M Dumas; Simon J A van den Bogaard; Margot E Ruber; Ralf R Reilman; Julie C Stout; David Craufurd; Stephen L Hicks; Chris Kennard; Sarah J Tabrizi; Mark A van Buchem; Jeroen van der Grond; Raymund A C Roos
Journal:  Hum Brain Mapp       Date:  2011-01-24       Impact factor: 5.038

9.  A preliminary diffusional kurtosis imaging study of Parkinson disease: comparison with conventional diffusion tensor imaging.

Authors:  Koji Kamagata; Hiroyuki Tomiyama; Taku Hatano; Yumiko Motoi; Osamu Abe; Keigo Shimoji; Kouhei Kamiya; Michimasa Suzuki; Masaaki Hori; Mariko Yoshida; Nobutaka Hattori; Shigeki Aoki
Journal:  Neuroradiology       Date:  2014-01-28       Impact factor: 2.804

10.  White matter impairment in Rett syndrome: diffusion tensor imaging study with clinical correlations.

Authors:  A Mahmood; G Bibat; A-L Zhan; I Izbudak; L Farage; A Horska; S Mori; S Naidu
Journal:  AJNR Am J Neuroradiol       Date:  2009-10-15       Impact factor: 3.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.